RxDoctor Payments Data

John Lee, MD

Otolaryngology · Rogers, ARNPI 1154389344

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,523 of the $2,000 with a category attached, or 76.2%. It is spread thinly across 18 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $582 and has fallen 87.7% since, to $71 in 2025.

$2,000in general payments, 2019–2025

Across 71 payments — averaging $28.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$471
  • Regeneron Healthcare Solutions, Inc.$367
  • Sanofi$326
  • Cochlear Americas$151
  • Sanofi-aventis U.S. LLC$130
  • Stryker$111
  • plus $444 from 12 others

What the payments were for

  • Travel & lodging$40220%
  • Food & beverage$1,52376%
  • Education$754%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,000 in reported general payments places this provider in the 70th percentile of 72 otolaryngology providers in Arkansas.

See all otolaryngology providers in Arkansas

Medicare billing

Part B allowed, 2024
$54,873
Medicare patients
302
Services billed
566

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dexamethasone Sodium Phosphate40$1,851
Prednisolone Acetate37$1,156
Levothyroxine Sodium100$566
Ipratropium Bromide12$534
Fluticasone Propionate32$483
Montelukast Sodium17$227
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen22$156
Ofloxacin14$94
Ondansetron OdtOndansetron11$50
Cephalexin13$35

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Rogers

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →